Neuren set for FDA talks on trial to treat developmental genetic disorders
Neuren Pharmaceuticals is set to enter talks with the Us Food and Drug Administration about its upcoming trial.
The Watchlist
Previous Video
Next Video
I88
INFINI RESOURCES LIMITED
Charles Armstrong, MD
Charles Armstrong
MD
Previous Video
Next Video
SPONSORED BY The Market Online